Clinical Trials Logo

Clinical Trial Summary

Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.


Clinical Trial Description

Past studies have examined different doses of ketorolac administered to patients after spinal fusion surgery and found that 7.5 mg every 6 hours was as effective as 15 or 30 mg every 6 hours in decreasing postoperative pain and patient opiate consumption. Since ketorolac side effects such as gastrointestinal and surgical site bleeding seem to be dose related, utilizing a lower dose of ketorolac may be more efficacious. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02181426
Study type Interventional
Source Medical University of South Carolina
Contact
Status Completed
Phase N/A
Start date March 2012
Completion date December 15, 2016

See also
  Status Clinical Trial Phase
Completed NCT01879852 - Muscle Weakness and Post-traumatic Knee OA N/A
Terminated NCT03696836 - AIR (Artificial Implant for Medial Meniscus Replacement) Study N/A
Completed NCT04644640 - Telerehabilitation Following Meniscectomy N/A
Recruiting NCT04972331 - Degenerative Meniscus Without Osteoarthritis : Arthroscopic Partial Menisectomy Versus Platelet Rich Plasma (APM-PRP) N/A
Completed NCT03350204 - Biomechanical Osteoarthritis Outcomes in Meniscectomy Patients N/A
Completed NCT02136901 - The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System) N/A
Completed NCT02108496 - Verifying the Effectiveness of the NUsurface® System N/A
Completed NCT01158677 - Short Term Outcome After Meniscectomy
Completed NCT02872753 - Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy Phase 4
Enrolling by invitation NCT04717609 - Saphenous Nerve Block for Partial Meniscectomy Phase 3
Completed NCT01571102 - Impact of Physiotherapy on Short-term Outcome After Meniscectomy N/A
Terminated NCT00314457 - Efficacy Study of Continuous Intraarticular Infusion in Patients Undergoing Arthroscopic Knee and Shoulder Operations Phase 4